Increased phosphorylation of vimentin in noninfiltrative meningiomas

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Bouamrani, Ali ^a   Ramus, Claire ^a   Gay, Emmanuel ^b   Pelletier, Laurent ^a   Cubizolles, Myriam ^c   Brugière, Sabine ^d   Wion, Didier ^a   Berger, François ^a   Issartel, Jean Paul ^a,e  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Ciphergen Biosystems   (United States)

^d CEA GRENOBLE   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN HYDROLYSATE; TUMOR MARKER; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CYTOSKELETON; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PURIFICATION; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TISSUE SECTION; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MIDDLE AGED; MOLECULAR WEIGHT; PHOSPHORYLATION; PROTEOMICS;

ADULT; AGED; CLUSTER ANALYSIS; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MOLECULAR WEIGHT; PHOSPHORYLATION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 77949518757     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009238     Document Type: Article

References (42)

1. Petricoin EF, Liotta LA (2004) SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol 15: 24-30.
2. Schwartz SA, Weil RJ, Johnson MD, Toms SA, Capriolo RM (2004) Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 10: 981-987.
3. Bouamrani A, Ternier J, Ratel D, Bouamrani A, Ternier J, et al. (2006) Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin Chem 52: 2103-2106.
4. Diamandis EP (2003) Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 49: 1272-1275.
5. Paradis V, Degos F, Dargere D, Pham N, Belghiti J, et al. (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41: 40-47.
6. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, et al. (2004) Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 64: 5882-5890.
7. Wiesner A (2004) Detection of Tumor Markers with ProteinChip® Technology. Current Pharm Biotech 5: 45-67.
8. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
9. Black PM (1993) Meningiomas. Neurosurgery 32: 643-657.
10. Chamberlain MC (2004) Intracerebral Meningiomas. Curr Treat Options Neurol 26: 297-305.
11. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85: 2046-2056.
12. Schwechheimer K, Kartenbeck J, Moll R, Franke WW (1984) Vimentin filament-desmosome cytoskeleton of diverse types of human meningiomas. A distinctive diagnostic feature. Lab Invest 51: 584-591.
13. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
14. Bourges I, Ramus C, Mousson de Camaret B, Beugnot R, Remacle C, et al. (2004) Structural organization of mitochondrial human complex I: role of the ND4 and ND5 mitochondria-encoded subunits and interaction with the prohibitin. Biochem J 383: 491-499.
15. Yang HY, Lieska N, Shao D, Kriho V, Pappas GD (1994) Proteins of the intermediate filament cytoskeleton as markers for astrocytes and human astrocytomas. Mol Chem Neuropathol 21: 155-176.
16. Yung WK, Luna M, Borit A (1985) Vimentin and glial fibrillary acidic protein in human brain tumors. J Neurooncol 3: 35-38.
17. Chu YW, Seftor EA, Romer LH, Hendrix MJ (1996) Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol 148: 63-69.
18. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, et al. (1999) Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112: 4615-4625.
19. Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, et al. (2002) Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 52: 253-263.
20. Trog D, Yeghiazaryan K, Schild HH, Golubnitschaja O (2008) Up-regulation of vimentin expression in low-density malignant glioma cells as immediate and late effects under irradiation and temozolomide treatment. Amino Acids 34: 539-545.
21. Donhuijsen K, Schulz S (1989) Prognostic significance of vimentin positivity in formalin-fixed renal cell carcinomas. Pathol Res Pract 184: 287-291.
22. Heatley M, Maxwell P, Whiteside C, Toner P (1995) Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate. J Clin Pathol 48: 1031-1034.
23. Raymond WA, Leong AS (1989) Vimentin-a new prognostic parameter in breast carcinoma? J Pathol 158: 107-114.
24. Seshadri R, Raymond WA, Leong AS, Horsfall DJ, McCaul K (1996) Vimentin expression is not associated with poor prognosis in breast cancer. Int J Cancer 67: 353-356.
25. Singh S, Sadacharan S, Su S, Belldegrun A, Persad S, et al. (2003) Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. Cancer Res 63: 2306-2311.
26. Li ZM, Wen YJ, Yang HB, Qin G, Tian L, et al. (2008) Enhanced expression of human vimentin intermediate filaments in hepatocellular carcinoma cells decreases their proliferative and invasive abilities in vitro. Zhonghua Zhong Liu Za Zhi 30: 408-412.
27. Nakamura Y, Kominami A, Tsujimoto Y, Nakayama Y, Kitahashi T, et al. (2009) Actin and Vimentin proteins with N-terminal deletion detected in tumor-bearing rat livers induced by intraportal-vein injection of Ha-ras-transfected rat liver cells. Int J Cancer 124: 2512-2519.
28. Hong SH, Misek DE, Wang H, Puravs E, Hinderer R, et al. (2006) Identification of a Specific Vimentin Isoform That Induces an Antibody Response in Pancreatic Cancer. Biomark Insights 1: 175-183.
29. Vossenaar ER, Deprés N, Lapointe E, van der Heijden A, Lora M, et al. (2004) Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 6: R142-R150.
30. Bang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, et al. (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 56: 2503-2511.
31. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, et al. (2006) Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 116: 869-871.
32. Slawson C, Lakshmanan T, Knapp S, Hart GW (2008) A mitotic GlcNAcylation/ phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. Mol Biol Cell 19: 4130-4140.
33. Ando S, Tanabe K, Gonda Y, Sato C, Inagaki M (1989) Domain- and sequencespecific phosphorylation of vimentin induces disassembly of the filament structure. Biochemistry 28: 2974-2979.
34. Ando S, Tokui T, Yamauchi T, Sugiura H, Tanabe K, et al. (1991) Evidence that Ser-82 is a unique phosphorylation site on vimentin for Ca2(+)-calmodul-independent protein kinase II. Biochem Biophys Res Commun 175: 955-962.
35. Chou YH, Ngai KL, Goldman R (1991) The regulation of intermediate filament reorganization in mitosis. p34cdc2 phosphorylates vimentin at a unique N-terminal site. J Biol Chem 266: 7325-7328.
36. Huang TJ, Lee TT, Lee WC, Lai YK, Yu JS, et al. (1994) Autophosphorylation-dependent protein kinase phosphorylates Ser25, Ser38, Ser65, Ser71, and Ser411 in vimentin and thereby inhibits cytoskeletal intermediate filament assembly. J Protein Chem 13: 517-525.
37. Nakamura Y, Hashimoto R, Amano M, Nagata K, Matsumoto N, et al. (2000) Localized phosphorylation of vimentin by rho-kinase in neuroblastoma N2a cells. Genes Cells 5: 823-837.
38. Cheng TJ, Tseng YF, Chang WM, Chang MD, Lai YK (2003) Retaining of the assembly capability of vimentin phosphorylated by mitogen-activated protein kinase-activated protein kinase-2. J Cell Biochem 89: 589-602.
39. Matsuzawa K, Kosako H, Inagaki N, Shibata H, Mukai H, et al. (1997) Domain-specific phosphorylation of vimentin and glial fibrillary acidic protein by PKN. Biochem Biophys Res Commun 234: 621-625.
40. Li QF, Spinelli AM, Wang R, Anfinogenova Y, Singer HA, et al. (2006) Critical role of vimentin phosphorylation at Ser-56 by p21-activated kinase in vimentin cytoskeleton signaling. J Biol Chem 281: 34716-24. Epub 2006 Sep 20.
41. Whipple RA, Balzer EM, Cho EH, Matrone MA, Yoon JR, et al. (2008) Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells. Cancer Res 68: 5678-5688.
42. Tsujimura K, Ogawara M, Takeuchi Y, Imajoh-Ohmi S, Ha MH, et al. (1994) Visualization and function of vimentin phosphorylation by cdc2 kinase during mitosis. J Biol Chem 269: 31097-31106.